UA115989C2 - Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії - Google Patents
Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої діїInfo
- Publication number
- UA115989C2 UA115989C2 UAA201500353A UAA201500353A UA115989C2 UA 115989 C2 UA115989 C2 UA 115989C2 UA A201500353 A UAA201500353 A UA A201500353A UA A201500353 A UAA201500353 A UA A201500353A UA 115989 C2 UA115989 C2 UA 115989C2
- Authority
- UA
- Ukraine
- Prior art keywords
- muscorinic
- antagonists
- dry powder
- long acting
- powder inhaler
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Abstract
Винахід стосується фармацевтичної композиції для інгаляції, що містить антагоністи мускаринових рецепторів тривалої дії (ТДМА) у формі сухого порошку в суміші з фармацевтично прийнятним носієм, і їх застосування для лікування респіраторного патологічного стану, вибраного з астми, хронічної обструктивної хвороби легенів (ХОХЛ) та інших обструктивних захворювань дихальних шляхів.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201207842 | 2012-07-05 | ||
TR201210438 | 2012-09-12 | ||
TR201300194 | 2013-01-07 | ||
PCT/TR2013/000193 WO2014007768A1 (en) | 2012-07-05 | 2013-06-24 | Dry powder inhaler compositions comprising long acting muscorinic antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
UA115989C2 true UA115989C2 (uk) | 2018-01-25 |
Family
ID=48699691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201500353A UA115989C2 (uk) | 2012-07-05 | 2013-06-24 | Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії |
Country Status (6)
Country | Link |
---|---|
US (1) | US20150150802A1 (uk) |
EP (1) | EP2682099B1 (uk) |
EA (1) | EA036153B1 (uk) |
GE (1) | GEP201706672B (uk) |
UA (1) | UA115989C2 (uk) |
WO (1) | WO2014007768A1 (uk) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201402556D0 (en) | 2014-02-13 | 2014-04-02 | Crystec Ltd | Improvements relating to inhalable particles |
EP3203983A1 (en) * | 2014-10-08 | 2017-08-16 | Eratech S.r.l. | Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation |
TR201712424A2 (tr) * | 2017-08-21 | 2019-03-21 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Kuru toz i̇nhalasyon bi̇leşi̇mleri̇ |
MX2021014343A (es) * | 2019-05-24 | 2022-01-06 | Glenmark Pharmaceutical Ltd | Una composicion de polvo inhalable de dosis fijas que comprende glicopirronio, formoterol y propionato de fluticasona. |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3345722A1 (de) | 1983-12-17 | 1985-06-27 | Boehringer Ingelheim KG, 6507 Ingelheim | Inhalator |
DE4140689B4 (de) | 1991-12-10 | 2007-11-22 | Boehringer Ingelheim Kg | Inhalationspulver und Verfahren zu ihrer Herstellung |
EP1430887A1 (de) | 2000-10-12 | 2004-06-23 | Boehringer Ingelheim Pharma GmbH & Co.KG | Tiotropium-haltige Inhalationspulver |
DE10126924A1 (de) | 2001-06-01 | 2002-12-05 | Boehringer Ingelheim Pharma | Inhalationskapseln |
DE10141376A1 (de) | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Inhalationspulvern |
KR20090057477A (ko) | 2001-09-14 | 2009-06-05 | 글락소 그룹 리미티드 | 호흡기 질환 치료용 펜에탄올아민 유도체 |
US8337816B2 (en) | 2001-09-17 | 2012-12-25 | Glaxo Group Limited | Dry powder medicament formulations |
DE10212264A1 (de) | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
GB0219513D0 (en) | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Inhalation compositions including coarse carrier |
US20090298742A1 (en) * | 2006-08-09 | 2009-12-03 | Glaxo Group Limited | Process for manufacturing lactose |
EP1894568A1 (en) * | 2006-08-31 | 2008-03-05 | Novartis AG | Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
EP1944018A1 (en) * | 2007-01-10 | 2008-07-16 | CHIESI FARMACEUTICI S.p.A. | Micronised particles of low-dosage strength active agents for powder formulations for inhalation |
AU2008218962B2 (en) | 2007-02-23 | 2013-03-14 | Theravance Biopharma R&D Ip, Llc | Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists |
ES2425592T3 (es) | 2007-04-24 | 2013-10-16 | Theravance, Inc. | Compuestos de amonio cuaternario de utilidad como antagonistas de los receptores muscarínicos |
PT2197841E (pt) | 2007-09-07 | 2012-01-02 | Theravance Inc | Compostos contendo guanidina úteis como antagonistas do receptor muscarínico |
EP2440196A4 (en) * | 2009-06-09 | 2013-01-02 | Elevation Pharmaceuticals Inc | TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY ADMINISTRATION OF BETA 2 NEBULIZED AGONIST OR A COMBINATION OF BETA 2 NEBULIZED AGONIST AND ANTICHOLINERGIC |
GB0918450D0 (en) * | 2009-10-21 | 2009-12-09 | Innovata Ltd | Composition |
WO2011093813A1 (en) | 2010-01-28 | 2011-08-04 | Mahmut Bilgic | Dry powder pharmaceutical composition comprising tiotropium and fluticasone |
TR201000623A2 (tr) * | 2010-01-28 | 2011-08-22 | B�Lg�� Mahmut | Yeni tiotropyum kombinasyonu. |
WO2011152804A2 (en) | 2010-06-03 | 2011-12-08 | Mahmut Bilgic | Process for dry powder formulations |
WO2011160920A1 (en) | 2010-06-22 | 2011-12-29 | Chiesi Farmaceutici S.P.A. | Dry powder formulation comprising an antimuscarinic drug |
PT3470057T (pt) * | 2010-09-29 | 2021-12-03 | Pulmatrix Operating Co Inc | Pós secos catiónicos compreendendo sais de magnésio |
-
2013
- 2013-06-24 US US14/412,094 patent/US20150150802A1/en not_active Abandoned
- 2013-06-24 EA EA201590036A patent/EA036153B1/ru not_active IP Right Cessation
- 2013-06-24 UA UAA201500353A patent/UA115989C2/uk unknown
- 2013-06-24 GE GEAP201313715A patent/GEP201706672B/en unknown
- 2013-06-24 WO PCT/TR2013/000193 patent/WO2014007768A1/en active Application Filing
- 2013-07-04 EP EP13175125.7A patent/EP2682099B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
EA201590036A1 (ru) | 2015-09-30 |
WO2014007768A1 (en) | 2014-01-09 |
EP2682099A1 (en) | 2014-01-08 |
EP2682099B1 (en) | 2020-09-02 |
EA036153B1 (ru) | 2020-10-06 |
US20150150802A1 (en) | 2015-06-04 |
GEP201706672B (en) | 2017-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120605T1 (el) | Παρασκευασμα ξηρης σκονης που περιλαμβανει εναν αναστολεα φωσφοδιεστερασης | |
WO2012110770A3 (en) | Combination of glycopyrrolate and a beta2 -agonist | |
WO2013021199A3 (en) | Eutectic mixture for pulmonary administration | |
EP2682108A3 (en) | Dry Powder Inhalers Comprising a Carrier Other Than Lactose and a Ternary Component | |
WO2014016548A3 (en) | Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient | |
PH12017502087B1 (en) | Tiotropium inhalation solution for nebulization | |
UA101652C2 (uk) | Композиція для інгаляції, що містить аклідиній для лікування астми та хронічного обструктивного захворювання легень | |
PH12014502662A1 (en) | Novel dosage form and formulation of abediterol | |
EP2682097A3 (en) | Dry Powder Inhalers Comprising A Carrier Other Than Lactose | |
WO2014007770A3 (en) | Inhalation compositions comprising corticosteroid and sorbitol | |
EA201201395A1 (ru) | Кнопочное устройство мундштука ингалятора сухого порошка | |
WO2014007781A3 (en) | Inhalation compositions | |
EA201201397A1 (ru) | Ингалятор, содержащий расслаиваемую блистерную упаковку | |
EA201201391A1 (ru) | Ингалятор | |
UA115989C2 (uk) | Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії | |
WO2014007771A3 (en) | Inhalation compositions comprising muscarinic receptor antagonist | |
EA201201392A1 (ru) | Кнопочное устройство мундштука ингалятора сухого порошка | |
EA201201393A1 (ru) | Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка | |
EA201201389A1 (ru) | Ингалятор, создающий турбулентность | |
MX2016001539A (es) | Particulas inhalables que comprenden tiotropio e indacaterol. | |
EA201201394A1 (ru) | Ингалятор для доставки лекарственного средства в виде сухого порошка | |
WO2019098969A3 (en) | Dry powder compositions for inhalation | |
BR112015004810A2 (pt) | preparações de tiotrópio | |
TR200909788A2 (tr) | Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu | |
MY191295A (en) | Pharmaceutical composition containing budesonide and formoterol |